Literature DB >> 20623294

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.

Costantino Iadecola1.   

Abstract

There is increasing evidence that cerebrovascular dysfunction plays a role not only in vascular causes of cognitive impairment but also in Alzheimer's disease (AD). Vascular risk factors and AD impair the structure and function of cerebral blood vessels and associated cells (neurovascular unit), effects mediated by vascular oxidative stress and inflammation. Injury to the neurovascular unit alters cerebral blood flow regulation, depletes vascular reserves, disrupts the blood-brain barrier, and reduces the brain's repair potential, effects that amplify the brain dysfunction and damage exerted by incident ischemia and coexisting neurodegeneration. Clinical-pathological studies support the notion that vascular lesions aggravate the deleterious effects of AD pathology by reducing the threshold for cognitive impairment and accelerating the pace of the dementia. In the absence of mechanism-based approaches to counteract cognitive dysfunction, targeting vascular risk factors and improving cerebrovascular health offers the opportunity to mitigate the impact of one of the most disabling human afflictions.

Entities:  

Mesh:

Year:  2010        PMID: 20623294      PMCID: PMC3001188          DOI: 10.1007/s00401-010-0718-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  132 in total

Review 1.  Endothelial influences on cerebrovascular tone.

Authors:  Jon Andresen; Nadeem I Shafi; Robert M Bryan
Journal:  J Appl Physiol (1985)       Date:  2006-01

2.  White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury.

Authors:  Malee S Fernando; Julie E Simpson; Fiona Matthews; Carol Brayne; Claire E Lewis; Robert Barber; Raj N Kalaria; Gill Forster; Filomena Esteves; Stephen B Wharton; Pamela J Shaw; John T O'Brien; Paul G Ince
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

Review 3.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

4.  The effects of additional pathology on the cognitive deficit in Alzheimer disease.

Authors:  Z Nagy; M M Esiri; K A Jobst; J H Morris; E M King; B McDonald; C Joachim; S Litchfield; L Barnetson; A D Smith
Journal:  J Neuropathol Exp Neurol       Date:  1997-02       Impact factor: 3.685

5.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

6.  Reduced cerebral blood flow response and compensation among patients with untreated hypertension.

Authors:  J R Jennings; M F Muldoon; C Ryan; J C Price; P Greer; K Sutton-Tyrrell; F M van der Veen; C C Meltzer
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

Review 7.  The role of cerebral ischemia in Alzheimer's disease.

Authors:  R N Kalaria
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

8.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

Authors:  J A Schneider; R S Wilson; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

9.  Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain.

Authors:  K Jendroska; W Poewe; S E Daniel; J Pluess; H Iwerssen-Schmidt; J Paulsen; S Barthel; L Schelosky; J Cervós-Navarro; S J DeArmond
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  A Heyman; G G Fillenbaum; K A Welsh-Bohmer; M Gearing; S S Mirra; R C Mohs; B L Peterson; C F Pieper
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

View more
  214 in total

Review 1.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

2.  Impaired Cerebral Hemodynamics and Cognitive Performance in Patients with Atherothrombotic Disease.

Authors:  Salo Haratz; Galit Weinstein; Noa Molshazki; Michal Schnaider Beeri; Ramit Ravona-Springer; Oleg Marzeliak; Uri Goldbourt; David Tanne
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Multimorbidity and Risk of Mild Cognitive Impairment.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Ruth H Cha; Walter K Kremers; Jennifer L St Sauver; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Ronald C Petersen; Rosebud O Roberts
Journal:  J Am Geriatr Soc       Date:  2015-08-27       Impact factor: 5.562

4.  The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension.

Authors:  Carmen Capone; Giuseppe Faraco; Laibaik Park; Xian Cao; Robin L Davisson; Costantino Iadecola
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

5.  Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys).

Authors:  Olivia M D'Angelo; Jeromy Dooyema; Cynthia Courtney; Lary C Walker; Eric Heuer
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

6.  Innate immunity receptor CD36 promotes cerebral amyloid angiopathy.

Authors:  Laibaik Park; Joan Zhou; Ping Zhou; Rose Pistick; Sleiman El Jamal; Linda Younkin; Joseph Pierce; Andrea Arreguin; Josef Anrather; Steven G Younkin; George A Carlson; Bruce S McEwen; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 7.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

Review 8.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

9.  Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  P A Dacks; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

Review 10.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.